Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Rankning i aktier #36445
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Aktiekurs
$1.73
Senast synkroniserad: 2025-06-17
Marknadsvärde
$2.55M
Förändring (1 dag)
-0.29%
Förändring (1 år)
-79.71%
Land
US
Handel Eiger BioPharmaceuticals, Inc. (EIGR)

Kategori

Healthcare
Antal utestående aktier för Eiger BioPharmaceuticals, Inc. (EIGR)
Antal utestående aktier per December 2023: 1.48M
Enligt de senaste finansiella rapporterna och aktiekursen för Eiger BioPharmaceuticals, Inc. är det aktuella antalet utestående aktier 1.48M. I slutet av December 2022 hade företaget 1.39M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Eiger BioPharmaceuticals, Inc. (EIGR) från 2016 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 1.48M 0.22%
2023 1.48M 6.39%
2022 1.39M 22.64%
2021 1.13M 20.61%
2020 938.11K 23.51%
2019 759.52K 66.18%
2018 457.03K 57.09%
2017 290.93K 45.30%
2016 200.23K 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 17,061.24%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 26,665.85%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 32,269.92%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 4,103.15%
NL